health
-
What Clinical Trials Really Show About Tigilanol Tiglate from the Blushwood Berry
A viral social media post revived interest in the rainforest drug, but current human trials reveal targeted local results rather than a…
-
MK615 Apricot Extract: Lab Promise vs. Limited Human Trial Data
While viral clips claim MK615 kills 95% of cancer cells, a small Phase I trial showed only disease stabilization, not tumor shrinkage,…
-
Thymalin’s Immune Claims Rest on One Russian Research Group, Not Western Trials
The Russian thymus peptide promoted online as an immune booster lacks FDA approval and independent Western trials, relying on a single Soviet-era…
-
Long COVID Linked to 14 Percent Higher Risk of New High Blood Pressure, Swedish Study Finds
Discover the new study linking Long COVID to a 14 percent higher risk of hypertension, and learn why cardiovascular monitoring matters now.
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
China’s approval of satri-cel marks a milestone for solid tumor treatment, introducing a targeted cellular therapy for advanced gastric cancer.
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
The FDA’s August 2026 approval of iberdomide introduces a new class of cancer drugs for patients with relapsed or refractory multiple myeloma.
-
Moderna and Merck’s Personalized Melanoma Vaccine Cuts Recurrence Risk by 42% in Late-Stage Trial
By sequencing individual tumors to target unique neoantigens, Moderna’s platform creates bespoke vaccines in nine weeks, cutting melanoma recurrence risk by 42%.
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
A phase 1 trial of an engineered CD40 antibody published in Cancer Cell found tumor shrinkage in half of 12 patients, with…
-
FDA Approves At-Home Subcutaneous Skyrizi Start for Adults With Crohn’s Disease
Examining the clinical performance, mechanism, and market impact of AbbVie’s IL-23 inhibitor following its latest subcutaneous induction approval.
-
Sugary Drinks Linked to Higher Teen Anxiety and Depression Risk in Australian Study
A three‑year study of 6,500 Australian adolescents shows daily sugary‑drink intake increases the odds of meeting screening thresholds for depression and anxiety,…
-
How Liquid Biopsy Is Transforming Cancer Monitoring and Early Detection Strategies
Non-invasive blood tests are moving beyond niche use to become vital tools for tracking treatment response, detecting recurrence, and screening for cancer.
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
The 2026 AACR Cancer Progress Report highlights a rise in survival rates and the emergence of innovative drug classes like PROTACs and…
-
Viatris Secures FDA Approval for RYZUMVI to Treat Presbyopia in Adults
Viatris wins FDA approval for RYZUMVI to treat presbyopia, adding a new option for aging eyes while seeking a U.S. commercial partner.
-
European Regulators Back Breakthrough Pancreatic Cancer Drug Rasonque
The EMA has recommended approval for daraxonrasib, a daily pill that doubles survival rates for patients with metastatic pancreatic adenocarcinoma.
-
How a Hidden Fat-Sensing Protein Could Unlock Immunotherapy for Deadly Colorectal Cancers
A new study reveals how tweaking a single molecular switch in immune cells could turn ‘untreatable’ tumors into immunotherapy responders—without headlines.
-
Thyroid Eye Disease Affects 16 in 100,000 Women Yearly, Smoking Multiplies Risk
Thyroid eye disease, linked to Graves’ disease, occurs in 16 per 100,000 women annually, with smoking increasing risk nearly eightfold and severe…
-
Generalized Myasthenia Gravis: Autoimmune Attack on Nerve-Muscle Junction Causes Progressive Weakness
Generalized myasthenia gravis is an autoimmune disorder where antibodies destroy acetylcholine receptors, leading to muscle weakness that worsens with activity and improves…
-
FDA expands Anktiva approval to cover papillary-only bladder cancer, first treatment for this group
The FDA has broadened Anktiva’s use with BCG to include patients with BCG-unresponsive, high-grade papillary-only non-muscle-invasive bladder cancer, offering a bladder-preserving option…
-
WHO Says 1.1 Billion Live With Obesity as Sleep, Stress and Hormones Shape Weight
Gurugram, June 19 — The World Health Organization now calls obesity one of the fastest-growing health concerns globally. That label carries weight.…
-
Stanford-Developed Orca-T Wins FDA Approval as First Regulatory T Cell Therapy for Blood Cancer Transplants
STANFORD, October 10 — Stanford Medicine administered the world’s first commercial dose of Orca-T on October 7, 2026, marking the therapy’s debut…
-
Academic Pioneers to Pharma Giants Drive CAR-T Therapy
PHILADELPHIA, July 7, 2026 — Dr. Carl June, director of the Center for Cellular Immunotherapies at the University of Pennsylvania, is widely…
-
Abdominal Obesity Plus Vitamin D Deficiency Doubles Death Risk in Older Adults
NEW YORK, September 20 — A study of more than 5,500 people over the age of 50 has found that those with…
-
Doctors Investigate Environmental and Lifestyle Factors Behind Millennial Rectal Cancer Rise
Doctors are asking a hard question about people born after 1980. They want to know what changed. Rectal cancer is rising in…
-
New Blood Test Detects Pancreatic Cancer at Precancerous Stage
BALTIMORE, September 17 — A new liquid biopsy blood test can detect pancreatic cancer at its earliest stages, including when it is…
Most read
-
Martin Lewis Warns Savers With £10,000 or More They Could Owe Tax on Interest
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Axos Offers 5.00% Savings Rate for Six Months After Fed Hike, With Strings Attached
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Understanding Metastatic Prostate Cancer Prognosis and Modern Treatment Pathways
-
Nangibotide Targets Acute-on-Chronic Liver Failure With Phase 2 Data Due 2027
-
SABR Versus Surgery: New Study Reveals Mortality Gap for Early-Stage Lung Cancer
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992